Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...
News Medical on MSN2d
New antibody reduces tumor growth in treatment-resistant breast and ovarian cancersA new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new ...
Astellas Pharma’s strong pipeline and revenue growth support a positive outlook. See why ALPMF stock is a "Buy," driven by ...
Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...
Geoffrey Shouse, DO, PhD, discusses the growing interest in bispecific antibodies within the field of oncology.
In this week’s edition of the biotech bi-weekly, learn more about CRAIC technologies’ 5D Spectral Surface Mapping solution, ...
Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.
Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...
SAN DIEGO and SUZHOU, China, March 13, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene”) (Nasdaq: ADAG), a company ...
Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback